Ruiying Han

发表

Choosing Optimal Antibiotics for the Treatment of Patients Infected With Enterobacteriaceae: A Network Meta-analysis and Cost-Effectiveness Analysis

Taotao Wang, Yalin Dong, Yan Wang, 2021, Frontiers in Pharmacology.

Determining the optimal PD‐1/PD‐L1 inhibitors for the first‐line treatment of non‐small‐cell lung cancer with high‐level PD‐L1 expression in China

Yalin Dong, Yalin Dong, Yan Wang, 2021, Cancer medicine.

Diagnostic accuracy of Raman spectroscopy in oral squamous cell carcinoma

Xuelei Ma, Juan Huang, Ruiying Han, 2022, Frontiers in Oncology.

Prognostic Significance of SQSTM1 in Breast Cancer: A Comprehensive Analysis

Yuzhu Dong, Qian Du, Yalin Dong, 2020 .

Optimizing Antimicrobial Dosing for Critically Ill Patients with MRSA Infections: A New Paradigm for Improving Efficacy during Continuous Renal Replacement Therapy

Yulan Qiu, Taotao Wang, Qian Du, 2022, Pharmaceutics.

Clinical Efficacy and Cost-Effectiveness of β-Lactam/β-Lactamase Inhibitor Combinations and Carbapenems in Liver Cirrhosis Patients with Gram-Negative Bacteria Bloodstream Infection

J. Lei, Taotao Wang, Yuzhu Dong, 2020, Infection and drug resistance.

Pharmacokinetic/Pharmacodynamic Adequacy of Novel β-Lactam/β-Lactamase Inhibitors against Gram-Negative Bacterial in Critically Ill Patients

Taotao Wang, Dan Sun, Yalin Dong, 2021, Antibiotics.

Clinical applications of circulating tumor DNA in monitoring breast cancer drug resistance.

Qian Du, Dan Sun, Yalin Dong, 2020, Future oncology.

Evaluation of the current guidelines for antibacterial therapy strategies in patients with cirrhosis or liver failure

Taotao Wang, Yuzhu Dong, Qian Du, 2022, BMC Infectious Diseases.

Does two-step infusion improve the pharmacokinetics/pharmacodynamics target attainment of meropenem in critically ill patients?

Taotao Wang, Dan Sun, Ruiying Han, 2024, Journal of pharmaceutical sciences.